So Disney just announced they're getting a new CEO, and honestly? It's about time. Meet Josh D'Amaro, the guy who's been running Disney's theme parks and apparently still rides the attractions himself to make sure they don't suck. That's either dedication or the best job perk ever. Here's the deal: Disney has been having what you might call a "rough patch" lately. And by rough patch, I mean their stock has dropped 42% over five years while everyone else was making money hand over fist. Ouch. The Bob Saga Continues Remember Bob Iger? The guy who bought Marvel, Star Wars, and basically everyt...

So Booking Holdings (BKNG) decided to take a little tumble yesterday, dropping 3.56% while the rest of the market was having its own mini-meltdown. You know, just your typical Tuesday in 2026 where a stock worth over $4,000 per share decides to shed some weight. Here's the thing about BKNG – when a stock that expensive moves, it's like watching a luxury yacht hit a speed bump. The company that basically owns your vacation planning (you know, the one behind Booking.com, Priceline, and about a dozen other sites you've definitely used) closed at $4,159.10, which sounds impressive until you reali...

The FDA said no. Then it said yes. And Moderna shareholders are having a very good Wednesday because of it. Shares of the biotech company surged more than 6% after Moderna announced that the Food and Drug Administration reversed its earlier decision and agreed to review the company’s experimental mRNA flu vaccine, mRNA-1010. Just last week, the FDA had refused to even accept the application for review — citing the lack of a comparison study with a vaccine currently used by older adults. The reversal came after Moderna made what the company called "concessions," though the specifics remain vag...

When the biggest chip company on the planet starts selling its stakes in AI startups, you pay attention. Nvidia’s latest 13F filing — dropped Tuesday after the bell — reveals the AI kingmaker has been quietly reshuffling its investment portfolio, and the moves tell a story about where the smart money thinks this AI cycle is actually heading. The exits were surgical. Nvidia dumped its entire positions in Applied Digital, ARM Holdings, Recursion Pharmaceuticals, and WeRide during the fourth quarter of 2025. Applied Digital shares cratered Wednesday morning on the news, and Recursion and WeRide ...

For years, Wall Street treated Palantir Technologies like that friend who is clearly talented but charges way too much for dinner. The data analytics company had a cult following among retail investors, but analysts kept their distance, turned off by a valuation that made nosebleed seats look cheap. That dynamic just flipped. After Palantir shares tumbled 25% since the start of 2026, more than half of Wall Street analysts now rate the stock the equivalent of a buy. That is a dramatic shift from December, when only 25% were willing to stick their necks out. Nothing changes sentiment like a pri...

Remember when everyone said software was eating the world? Well, plot twist: AI is now eating the software. For the past 15 years, Software-as-a-Service (SaaS) was basically a money printer. Build a decent dashboard, slap a monthly fee on it, and watch the cash roll in as companies hired more people who needed more "seats." It was beautiful in its simplicity. But here's the thing nobody saw coming: AI doesn't need a seat at the table. Think about it. If one AI agent can do the work of five junior analysts, companies don't just cut payroll—they cut software licenses too. Why pay $70 per mont...

Bayer's eight-year Roundup nightmare may finally have an expiration date — and the market can't decide if it's relieved or terrified. On Tuesday, Bayer's Monsanto unit filed a proposed $7.25 billion class-action settlement in Missouri state court designed to resolve roughly 65,000 pending lawsuits and cap future claims over a 21-year period. The lawsuits allege that Roundup, the world's most widely used weedkiller, causes non-Hodgkin lymphoma and other cancers. Bayer denies wrongdoing and maintains decades of studies show the product is safe. But the company has already paid about $10 billion...

When the people running a company start selling their own stock in size, the rest of us should probably pay attention. Right now, the insider buy/sell ratio across American public companies has crashed to 0.24 — meaning executives are buying just $0.24 of stock for every $1 they sell. That's one of the lowest readings on record, and well below the long-term average of 0.40. In plain English: the people closest to the numbers are heading for the exits while markets hover near all-time highs. The selling is particularly aggressive in AI data center stocks. At Oracle, the CEO sold 10,000 shares...

Meta and Nvidia just made every other chipmaker in the room nervous. On Tuesday, the two Silicon Valley giants announced a sweeping multiyear, multigenerational AI infrastructure deal. Meta will deploy millions of Nvidia chips across its U.S. data centers — including current-generation Blackwell GPUs, next-generation Vera Rubin systems arriving in 2027, and, for the first time ever at scale, Nvidia's standalone Grace CPUs. No financial terms were disclosed, but analyst Ben Bajarin of Creative Strategies estimated the deal is "certainly in the tens of billions of dollars" and expects a good ch...

Remember when everyone was obsessed with Nvidia and AI chips? Well, plot twist: the real money might be in the boring stuff nobody talks about – memory chips. And no, I'm not talking about your laptop's RAM. Here's what's happening: Applied Materials (AMAT) just dropped earnings that made Wall Street do a double-take. The stock jumped 12% after hours because this company – which makes the machines that make memory chips – basically said "we can't keep up with demand." The Memory Crisis Nobody Saw Coming While everyone was fighting over AI processors, a quiet crisis was brewing. Data centers...